Blood Test at Birth May Identify Babies at Risk of Sudden Infant Death Syndrome (SIDS)

Monday, 9 September 2024, 08:00

Blood tests at birth could potentially identify babies at increased risk of Sudden Infant Death Syndrome (SIDS). Researchers found that newborns with unusual patterns of metabolites in their blood were significantly more likely to succumb to SIDS. This breakthrough suggests early detection of underlying conditions related to SIDS may be possible.
LivaRava_Medicine_Default.png
Blood Test at Birth May Identify Babies at Risk of Sudden Infant Death Syndrome (SIDS)

Blood Test at Birth and SIDS Risk

Researchers at UC San Francisco have discovered a potential link between a specific metabolic pattern in newborn blood tests and an increased risk of Sudden Infant Death Syndrome (SIDS). The study analyzed metabolic blood panels from heel prick tests of 354 infants who unfortunately died from SIDS and compared them to healthy newborns with similar gestational age and birth weight.

Significant Findings on Metabolites

The findings revealed that newborns presenting an unusual pattern of metabolites were 14 times more likely to die from SIDS when compared to those exhibiting a low-risk metabolic profile. This emphasizes the possibility of early detection and intervention.

Implications for Future Research

This important research adds to a growing body of evidence suggesting that underlying conditions associated with SIDS may be identifiable shortly after birth, paving the way for future preventative strategies.


This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.


Related posts


Newsletter

Subscribe to our newsletter for the most accurate and current medical news. Stay updated and deepen your understanding of medical advancements effortlessly.

Subscribe